In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Neuropathology and Experimental Neurology

• Publication date

  1999-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00005072-199909000-00012PMID 10499444
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Developmental cell death: morphological diversity and multiple mechanisms

  2004cited by this paper
• Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation.

  1999cited by this paper
• Tau Protein Mutations Confirmed as Neuron Killers

  1998cited by this paper
• Alzheimer Disease: DMA Fragmentation Indicates Increased Neuronal Vulnerability, but not Apoptosis

  1998cited by this paper
• Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease

  1998cited by this paper
• Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury.

  1998cited by this paper
• Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia

  1998cited by this paper
• Methods for detecting and quantifying apoptosis.

  1998cited by this paper
• A suicide note from Alzheimer disease neurons?

  1998cited by this paper
• Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease.

  1998cited by this paper
• Trophic support promotes survival of bcl-x-deficient telencephalic cells in vitro

  1998cited by this paper
• Caspase Dependent DNA Fragmentation Might Be Associated with Excitotoxicity in Alzheimer Disease

  1998cited by this paper
• Expression of ced-3 and ced-9 homologs in Alzheimer's disease cerebral cortex.

  1998cited by this paper
• Bcl-xL is an Antiapoptotic Regulator for Postnatal CNS Neurons

  1998cited by this paper
• Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease.

  1998cited by this paper
• Cell suicide for beginners

  1998cited by this paper
• Protection against beta-amyloid toxicity in primary neurons by paclitaxel (Taxol).

  1998cited by this paper
• In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system

  1998cited by this paper
• Aggregated Amyloid-β Protein Induces Cortical Neuronal Apoptosis and Concomitant “Apoptotic” Pattern of Gene Induction

  1997cited by this paper
• The role of amyloid in the pathogenesis of Alzheimer's disease.

  1997cited by this paper
• Role of calpain- and interleukin-1 beta converting enzyme-like proteases in the beta-amyloid-induced death of rat hippocampal neurons in culture.

  1997cited by this paper
• In Situ Labeling of Dying Cortical Neurons in Normal Aging and in Alzheimer’s Disease: Correlations with Senile Plaques and Disease Progression

  1996cited by this paper
• Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice

  1996cited by this paper
• Amyloid β Peptide of Alzheimer’s Disease Downregulates Bcl-2 and Upregulates Bax Expression in Human Neurons

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons

  1995cited by this paper
• Evidence for apoptotic cell death in Alzheimer's disease.

  1995cited by this paper
• Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system.

  1995cited by this paper
• Possible role of neuronal apoptosis in Alzheimer's disease.

  1994cited by this paper
• A Study of Apoptosis in Normal and Pathologic Nervous Tissue After In situ End‐Labeling of DNA Strand Breaks

  1994cited by this paper
• Ultrastructural analysis of beta-amyloid-induced apoptosis in cultured hippocampal neurons.

  1994cited by this paper
• beta-Amyloid neurotoxicity: a discussion of in vitro findings.

  1992cited by this paper
• A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

  1992cited by this paper
• Toxicity of synthetic A beta peptides and modeling of Alzheimer's disease.

  1992cited by this paper
• Methodological variables in the assessment of beta amyloid neurotoxicity.

  1992cited by this paper
• Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease.

  1991cited by this paper
• Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain.

  1990cited by this paper
• Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

  1990cited by this paper
• GRANULOVACUOLAR DEGENERATION IN THE AGEING BRAIN AND IN DEMENTIA

  1977cited by this paper
• Granulovacuolar degeneration of hippocampal pyramidal cells

  1972cited by this paper
• Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics

  1972cited by this paper

• The Intricate Role of Caspase-6 and Death Receptor-6 in Neurodegenerative Diseases.

  2025cites this paper
• Evidence that Alzheimer’s Disease Is a Disease of Competitive Synaptic Plasticity Gone Awry

  2024cites this paper
• The Effect of Continuous Positive Airway Pressure (CPAP) Therapy on Serum Caspase-3 Level in Patients with Obstructive Sleep Apnea (OSA)

  2024cites this paper
• Necrosis Links Neurodegeneration and Neuroinflammation in Neurodegenerative Disease

  2024cites this paper
• Endoplasmic reticulum unfolded protein response transcriptional targets of XBP-1s mediate rescue from tauopathy

  2024cites this paper
• Caspase‐6‐cleaved tau is relevant in Alzheimer's disease and marginal in four‐repeat tauopathies: Diagnostic and therapeutic implications

  2022cites this paper
• Neuronal cell death mechanisms in Alzheimer’s disease: An insight

  2022cites this paper
• Impact of Tau on Neurovascular Pathology in Alzheimer's Disease

  2021cites this paper
• A New Approach to Model Sporadic Alzheimer’s Disease by Intracerebroventricular Streptozotocin Injection in APP/PS1 Mice

  2021cites this paper
• Caspase-6-cleaved Tau fails to induce Tau hyperphosphorylation and aggregation, neurodegeneration, glial inflammation, and cognitive deficits

  2021cites this paper
• Caspase‐6‐cleaved tau is relevant in Alzheimer's disease but not in 4‐repeat tauopathies: Diagnostic and therapeutic implications

  2021cites this paper
• Dysregulated protein phosphorylation as main contributor of granulovacuolar degeneration at the first stages of NFT pathology.

  2021cites this paper
• Rare CASP6N73T variant associated with hippocampal volume exhibits decreased proteolytic activity, synaptic transmission defect, and neurodegeneration

  2021cites this paper
• Necrosome‐positive granulovacuolar degeneration is associated with TDP‐43 pathological lesions in the hippocampus of ALS/FTLD cases

  2020cites this paper
• Cell death and survival pathways in Alzheimer's disease: an integrative hypothesis testing approach utilizing -omic data sets.

  2020influential citation
• Detection of Active Caspase-3 in Mouse Models of Stroke and Alzheimer's Disease with a Novel Dual Positron Emission Tomography/Fluorescent Tracer [68Ga]Ga-TC3-OGDOTA

  2019cites this paper
• A review on shared clinical and molecular mechanisms between bipolar disorder and frontotemporal dementia.

  2019cites this paper
• Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in Alzheimer’s disease

  2019cites this paper
• Caspase vinyl sulfone small molecule inhibitors prevent axonal degeneration in human neurons and reverse cognitive impairment in Caspase-6-overexpressing mice

  2017influential citation
• Prospective clinical biomarkers of caspase-mediated apoptosis associated with neuronal and neurovascular damage following stroke and other severe brain injuries: Implications for chronic neurodegeneration

  2017cites this paper
• Hazelnut and neuroprotection: Improved memory and hindered anxiety in response to intra-hippocampal Aβ injection

  2017cites this paper
• RESTRICTION OF APOPTOSIS IN MATURE NEURONS BY MULTIPLE REDUNDANT BRAKES

  2016cites this paper
• Modélisation des phases précoces de la maladie d’Alzheimer par transfert de gènes

  2016cites this paper
• Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology

  2016cites this paper
• Increased Caspase-6 activity in the human anterior olfactory nuclei of the olfactory bulb is associated with cognitive impairment

  2016cites this paper
• Sigma Receptor Activation Mitigates Toxicity Evoked by the Convergence of Ischemia, Acidosis and Amyloid-beta

  2015cites this paper
• Targeting the Phosphatidylinositide-3 Kinase Pathway and the Mitogen-Activated-Protein Kinase Pathway through Thymosin-beta4, Exercise, and Negative Regulators to Promote Retinal Ganglion Cell Survival or Regeneration

  2015cites this paper
• Alzheimer's Disease, Drosophila melanogaster and Polyphenols.

  2015cites this paper
• Assembly and Interrogation of Alzheimer’s Disease Genetic Networks Reveal Novel Regulators of Progression

  2015cites this paper
• The molecular intersection between axon-specific pruning and neuronal apoptosis

  2014cites this paper
• 4-O-Methylhonokiol Attenuated Memory Impairment Through Modulation of Oxidative Damage of Enzymes Involving Amyloid- Generation and Accumulation in a Mouse Model of Alzheimer's Disease

  2014cites this paper
• Low‐dose total‐body carbon‐ion irradiations induce early transcriptional alteration without late Alzheimer's disease‐like pathogenesis and memory impairment in mice

  2014cites this paper
• The Effect of Acute LPS-Induced Immune Activation and Brain Insulin Signaling Disruption in a Diabetic Model of Alzheimer's Disease

  2014cites this paper
• Afobazole Activation of Sigma-1 Receptors Modulates Neuronal Responses to Amyloid-β

  2013cites this paper
• The Triggering Receptor Expressed on Myeloid Cells 2: “TREM-ming” the Inflammatory Component Associated with Alzheimer's Disease

  2013cites this paper
• Afobazole Activation of s-1 Receptors Modulates Neuronal Responses to Amyloid-b25–35

  2013cites this paper
• Caspases in Alzheimer’s Disease

  2013cites this paper
• Afobazole Activation of σ-1 Receptors Modulates Neuronal Responses to Amyloid-β25–35

  2013cites this paper
• Treadmill exercise represses neuronal cell death and inflammation during Aβ-induced ER stress by regulating unfolded protein response in aged presenilin 2 mutant mice

  2013cites this paper
• Caspase‐6 as a novel early target in the treatment of Alzheimer's disease

  2013influential citation
• The contribution of N-terminally modified amyloid beta to the etiology of Alzheimer's disease

  2012cites this paper
• Altered Mitochondrial Retrograde Signaling in Response to mtDNA Depletion or a Ketogenic Diet

  2012cites this paper
• Cdk5 Protein Inhibition and Aβ42 Increase BACE1 Protein Level in Primary Neurons by a Post-transcriptional Mechanism

  2012cites this paper
• Electron microscopist’s view of the Alzheimer’s plaque

  2012cites this paper
• Neurodegeneration in Alzheimer Disease: Role of Amyloid Precursor Protein and Presenilin 1 Intracellular Signaling

  2012cites this paper
• Mitochondria and Cell Bioenergetics: Increasingly Recognized Components and a Possible Etiologic Cause of Alzheimer's Disease

  2012cites this paper
• Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease.

  2012cites this paper
• The Small Chaperone Protein p23 and Its Cleaved Product p19 in Cellular Stress

  2012cites this paper
• Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

  2012cites this paper
• Granulovacuolar Degenerations Appear in Relation to Hippocampal Phosphorylated Tau Accumulation in Various Neurodegenerative Disorders

  2011cites this paper
• 4-O-Methylhonokiol Attenuated Memory Impairment Through Modulation of Oxidative Damage of Enzymes Involving Amyloid-β Generation and Accumulation in a Mouse Model of Alzheimer's Disease

  2011cites this paper
• Matter of life and death: the pharmacological approaches targeting apoptosis in brain diseases.

  2011cites this paper
• Neuropathological alterations in Alzheimer disease.

  2011cites this paper
• Possible involvement of programmed cell death pathways in the neuroprotective action of polyphenols.

  2011cites this paper
• and Alzheimer's disease

  2010cites this paper
• Apoptosis signaling associated with amyloid β-induced cellular dysfunction and degeneration : relevance for Alzheimer’s disease

  2010cites this paper
• Cellular pathology and apoptosis in experimental and human acute and chronic compressive myelopathy.

  2010cites this paper
• Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases

  2010cites this paper
• APOPTOSIS SIGNALING ASSOCIATED WITH AMYLOID -INDUCED CELLULAR DYSFUNCTION AND DEGENERATION

  2010cites this paper
• Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus.

  2010cites this paper
• Self-activation of Caspase-6 in vitro and in vivo: Caspase-6 activation does not induce cell death in HEK293T cells.

  2009cites this paper
• Stress kinases involved inTau phosphorylation in alzheimer’s disease, tauopathies and APP transgenic mice

  2009cites this paper
• Apoptosis and in vitro Alzheimer’s disease neuronal models

  2009cites this paper
• The role of death receptors in neural injury.

  2009cites this paper
• The pathology of APP transgenic mice: a model of Alzheimer's disease or simply overexpression of APP?

  2009cites this paper
• Neuroprotective Properties of Glycosaminoglycans: Potential Treatment for Neurodegenerative Disorders

  2008cites this paper
• Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer's disease.

  2008cites this paper
• Signal transduction in Alzheimer disease: p21‐activated kinase signaling requires C‐terminal cleavage of APP at Asp664

  2008cites this paper
• Targets of Caspase-6 Activity in Human Neurons and Alzheimer Disease*S

  2008cites this paper
• Differential regulation of apoptosis by caspase-mediated cleavage of phospholipase D isozymes.

  2008cites this paper
• Cell Injury , Repair , Aging and Apoptosis Neuronal Apoptosis and Autophagy Cross Talk in Aging PS / APP Mice , a Model of Alzheimer ’ s Disease

  2008cites this paper
• Caspase Activation in Alzheimer's Disease: Early to Rise and Late to Bed

  2008cites this paper
• Introspective analysis of amyloid as the cause of Alzheimer’s disease: alternative model proposed

  2008cites this paper
• The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy.

  2008cites this paper
• Apoptosis in Transgenic Mice Expressing the P301L Mutated Form of Human Tau

  2008cites this paper
• Involvement of subtype 1 metabotropic glutamate receptors in apoptosis and caspase-7 over-expression in spinal cord of neuropathic rats.

  2008cites this paper
• Dysfunction of amyloid precursor protein signaling in neurons leads to DNA synthesis and apoptosis.

  2007cites this paper
• The role of tau phosphorylation and cleavage in neuronal cell death.

  2007cites this paper
• The odour span task: a novel paradigm for assessing working memory in mice.

  2007cites this paper
• Rab5 Mediates an Amyloid Precursor Protein Signaling Pathway That Leads to Apoptosis

  2007cites this paper
• ROLE OF APOPTOSIS AND ITS MODULATION

  2007cites this paper
• Differential binding and activation of caspase‐3 in cultured hippocampal neurons by assembly forms of Aβ1–42

  2007cites this paper
• Amyloid Precursor Protein and Presenilin Involvement in Cell Signaling

  2007cites this paper
• Differential binding and activation of caspase‐3 in cultured hippocampal neurons by assembly forms of Aβ1–42

  2007cites this paper
• Tipping the apoptotic balance in Alzheimer's disease

  2007cites this paper
• Angiotensin-II-Rezeptorantagonisten und endotheliale Progenitorzellen: ein neuer therapeutischer Ansatz?

  2007cites this paper
• Chapter 21 – An Assessment of the Chances of Antiapoptotic Drug Therapy in Patients with Neurodegenerative Disorders

  2007cites this paper
• Elevation of cytoskeletal protein breakdown in aged Wistar rat brain.

  2006cites this paper
• Hypochlorous acid induces apoptosis of cultured cortical neurons through activation of calpains and rupture of lysosomes

  2006cites this paper
• Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer’s disease and tauopathies to granulovacuolar degeneration bodies

  2006cites this paper
• Nuclear Pore Complex Proteins in Alzheimer Disease

  2006cites this paper
• Caspase-3 cleaved spectrin colocalizes with neurofilament-immunoreactive neurons in Alzheimer's disease.

  2006cites this paper
• Immediate Early Genes, Inducible Transcription Factors and Stress Kinases in Alzheimer's Disease

  2006cites this paper
• Oncogenic parallels in Alzheimer disease

  2006cites this paper
• The cell cycle as a therapeutic target for Alzheimer's disease.

  2006cites this paper
• Differential susceptibility of naive and differentiated PC-12 cells to methylglyoxal-induced apoptosis: influence of cellular redox.

  2005cites this paper
• Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE).

  2005cites this paper
• Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and α-synuclein pathology

  2005cites this paper
• Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.

  2005cites this paper
• Activated caspase expression and apoptosis increase in keloids: cytochrome c release and caspase‐9 activation during the apoptosis of keloid fibroblast lines

  2005cites this paper